Viewing Study NCT01023048



Ignite Creation Date: 2024-05-05 @ 10:05 PM
Last Modification Date: 2024-10-26 @ 10:13 AM
Study NCT ID: NCT01023048
Status: COMPLETED
Last Update Posted: 2014-04-02
First Post: 2009-11-30

Brief Title: Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis PGD
Sponsor: Natera Inc
Organization: Natera Inc

Study Overview

Official Title: First Use of Parental Support TechnologyR for Single Gene Analysis Plus Aneuploidy Screening in Preimplantation Genetic Diagnosis
Status: COMPLETED
Status Verified Date: 2014-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: IVF008
Brief Summary: Gene Security Network has developed a novel technology called Parental SupportTM PS which is used for Preimplantation Genetic ScreeningDiagnosis PGSD during in vitro fertilization IVF This technology allows IVF physicians to identify embryos prior to transfer to the uterus which have the best chance of developing into healthy children The purpose of this study is to validate clinical use of PS to detect specific genetic mutations known to cause severe inheritable diseases in embryos produced by at-risk couples This may be done while simultaneously testing these embryos for aneuploidy This study will allow for first of its kind commercial PGSD testing to detect disease-associated genetic mutations together with aneuploidy screening
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None